Patrick M. Fernandes

Array ( [id] => 11390478 [patent_doc_number] => 09551716 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-01-24 [patent_title] => 'Method for diagnosis and prognosis of chronic obstructive pulmonary disease (COPD)' [patent_app_type] => utility [patent_app_number] => 14/890948 [patent_app_country] => US [patent_app_date] => 2014-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15297 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14890948 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10933047 [patent_doc_number] => 20140336068 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-13 [patent_title] => 'MAGNETIC IMMUNO DIGITAL PCR ASSAY' [patent_app_type] => utility [patent_app_number] => 14/272370 [patent_app_country] => US [patent_app_date] => 2014-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13664 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14272370 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11829936 [patent_doc_number] => 09726674 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-08-08 [patent_title] => 'PIIINP neo-epitope assay' [patent_app_type] => utility [patent_app_number] => 14/784512 [patent_app_country] => US [patent_app_date] => 2014-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 22 [patent_no_of_words] => 10431 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14784512 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9895962 [patent_doc_number] => 20150051161 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-19 [patent_title] => 'Methods for the Detection of Advanced Glycation Endproducts and Markers for Disease' [patent_app_type] => utility [patent_app_number] => 14/249451 [patent_app_country] => US [patent_app_date] => 2014-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 33021 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14249451 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10549492 [patent_doc_number] => 09274113 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-03-01 [patent_title] => 'Method for screening an agent preventing or treating cancer using glycyl-tRNA synthetase and cadherin' [patent_app_type] => utility [patent_app_number] => 14/249975 [patent_app_country] => US [patent_app_date] => 2014-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 14005 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14249975 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10919709 [patent_doc_number] => 20140322728 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-30 [patent_title] => 'Compositions and Methods for Assessing Gastrointestinal Health' [patent_app_type] => utility [patent_app_number] => 14/245841 [patent_app_country] => US [patent_app_date] => 2014-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10578 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14245841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9786202 [patent_doc_number] => 20140303021 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-09 [patent_title] => 'METHODS AND DEVICES FOR DETECTING OBSTRUCTIVE UROPATHY AND ASSOCIATED DISORDERS' [patent_app_type] => utility [patent_app_number] => 14/243659 [patent_app_country] => US [patent_app_date] => 2014-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 17680 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14243659 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9785714 [patent_doc_number] => 20140302534 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-09 [patent_title] => 'ANTI-CANINE N-TERMINAL PRO-ATRIAL NATRIURETIC PEPTIDE ANTIBODY, AND IMMUNOLOGICAL MEASUREMENT METHOD AND IMMUNOLOGICALLY MEASURING KIT USING THE SAME' [patent_app_type] => utility [patent_app_number] => 14/231069 [patent_app_country] => US [patent_app_date] => 2014-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12809 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14231069 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10701666 [patent_doc_number] => 20160047813 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-18 [patent_title] => 'INTERGRIN ALPHA V BETA 6 FOR DIAGNOSIS/PROGNOSIS OF COLORECTAL CARCINOMA' [patent_app_type] => utility [patent_app_number] => 14/779993 [patent_app_country] => US [patent_app_date] => 2014-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6278 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14779993 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10202738 [patent_doc_number] => 20150087727 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-26 [patent_title] => 'METHOD FOR RISK STRATIFICATION IN STABLE CORONARY ARTERY DISEASE' [patent_app_type] => utility [patent_app_number] => 14/223517 [patent_app_country] => US [patent_app_date] => 2014-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6629 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14223517 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10776594 [patent_doc_number] => 20160122751 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-05 [patent_title] => 'NUCLEIC ACID-TAGGED COMPOSITIONS AND METHODS FOR MULTIPLEXED PROTEIN-PROTEIN INTERACTION PROFILING' [patent_app_type] => utility [patent_app_number] => 14/777019 [patent_app_country] => US [patent_app_date] => 2014-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8111 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 28 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14777019 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9737287 [patent_doc_number] => 20140273005 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-18 [patent_title] => 'Magnecytometer For The Detection Of One Or More Analytes' [patent_app_type] => utility [patent_app_number] => 14/213301 [patent_app_country] => US [patent_app_date] => 2014-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 3186 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14213301 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10665065 [patent_doc_number] => 20160011209 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-14 [patent_title] => 'Application of N-terminomics to NETosis in inflammation' [patent_app_type] => utility [patent_app_number] => 14/771322 [patent_app_country] => US [patent_app_date] => 2014-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6935 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14771322 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10116870 [patent_doc_number] => 09151747 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2015-10-06 [patent_title] => 'Sucralose antibody and immunoassay' [patent_app_type] => utility [patent_app_number] => 14/209467 [patent_app_country] => US [patent_app_date] => 2014-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 4541 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14209467 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10656558 [patent_doc_number] => 20160002701 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-07 [patent_title] => 'Proximity Assay for In Situ Detection of Targets' [patent_app_type] => utility [patent_app_number] => 14/769892 [patent_app_country] => US [patent_app_date] => 2014-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 24641 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14769892 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10723732 [patent_doc_number] => 20160069881 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-10 [patent_title] => 'METHODS FOR DETECTING MOLECULES IN A SAMPLE' [patent_app_type] => utility [patent_app_number] => 14/778532 [patent_app_country] => US [patent_app_date] => 2014-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 25374 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 36 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14778532 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11643319 [patent_doc_number] => 09664683 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-05-30 [patent_title] => 'Profiling of signal pathway proteins to determine therapeutic efficacy' [patent_app_type] => utility [patent_app_number] => 14/194323 [patent_app_country] => US [patent_app_date] => 2014-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 63 [patent_no_of_words] => 31435 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 259 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14194323 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11199380 [patent_doc_number] => 09429584 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-08-30 [patent_title] => 'Antibody against insoluble fibrin' [patent_app_type] => utility [patent_app_number] => 14/770864 [patent_app_country] => US [patent_app_date] => 2014-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 19 [patent_no_of_words] => 17782 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14770864 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10548536 [patent_doc_number] => 09273149 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-03-01 [patent_title] => 'Methods and compositions for determining the purity of chemically synthesized nucleic acids' [patent_app_type] => utility [patent_app_number] => 14/192387 [patent_app_country] => US [patent_app_date] => 2014-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 12103 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14192387 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10657666 [patent_doc_number] => 20160003810 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-07 [patent_title] => 'A METHOD FOR ESTIMATING GFR (GLOMERULAR FILTRATION RATE) FROM MEASURED VALUE OF MEGALIN IN URINE' [patent_app_type] => utility [patent_app_number] => 14/768527 [patent_app_country] => US [patent_app_date] => 2014-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4242 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14768527 [rel_patent_id] =>[rel_patent_doc_number] =>)